KLK3 and posterior cortical atrophy: The test uses a combination of different forms of PSA (tPSA, fPSA and [–2] proPSA(p2PSA) and has shown improved ability to predict presence of PCa and clinically significant PCa at biopsy compared to total PSA [4,5].